keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Labradimil increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 | |
50 mg | Inquiry | $ 1,980.00 | |
100 mg | Inquiry | $ 2,500.00 |
Description | Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Labradimil increases carboplatin levels in brain tumors after pretreatment with dexamethasone. |
Synonyms | RMP-7, ALK-01-040, Receptor-mediated permeabiliser-7, DRG0182, DRG 0182, DRG-0182 |
Molecular Weight | 1098.29 |
Formula | C49H75N15O12S |
CAS No. | 159768-75-9 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Labradimil 159768-75-9 RMP-7 ALK-01-040 RMP 7 Receptor-mediated permeabiliser-7 DRG0182 DRG 0182 RMP7 DRG-0182 inhibitor inhibit